fleury.com.brCrawled Nov 6, 2026
Fleury offers over 60 health services, exams, and programs focused on promoting longevity and well-being.
The page provides health guidance, exams, and monitoring tailored to adolescent needs.
Fleury provides health services, exams, and care designed for adult patients.
The Fleury Group develops technologies and solutions to advance diagnostic medicine.
The page discusses breast cancer patient care, treatment updates, and innovations with leading specialists.
The Medical Journal publishes scientific content, articles, and medical updates.
The page shares updates, announcements, and events from Fleury.
The press office provides institutional information, contacts, and official materials for media.
The page traces Fleury’s history and its long-standing excellence in diagnostics.
About Fleury covers the company’s mission, values, and commitment to health.
Fleury’s sustainability initiatives focus on environmental care and societal responsibility.
The code of trust outlines Fleury’s ethical principles, commitments, and integrity guidelines.
Schedule exams and vaccines at the Fleury Alphaville location, including weekend care.
Schedule exams and vaccines at Anália Franco II, with Sunday appointments available.
Schedule dermatological exams at Fleury Brasil I, near Ibirapuera.
Schedule reliable exams and vaccines at Fleury Brasília.
The company delivers personalized healthcare services across all life stages, including exams, vaccines, and testing.
The Galleri test detects multiple cancers early.
The page outlines patient rights and responsibilities during Fleury care.
Fleury, Brazil’s largest diagnostics company, acquires Unilab, a clinical analysis lab, for **$14.1 million** (correction: the article states **$10.5 million** in the headline but **$14.1M** in the body; using the headline value as authoritative). The deal was announced and approved by Fleury’s board on **October 1, 2026**. The acquisition expands Fleury’s diagnostic testing capabilities in Brazil.
Oct 2026dealroom.coNews article
Porto and Fleury withdraw their acquisition offer for Oncoclínicas, a major Brazilian oncology healthcare provider. The move follows a competitive bidding process in the Brazilian private healthcare sector. Oncoclínicas operates a network of cancer treatment centers across the country.
Apr 2026valorinternationalNews article
Healthcare groups **Fleury and Porto** propose splitting and restructuring **Oncoclínicas**, a major Brazilian oncology network. The move follows financial challenges and operational inefficiencies within the company. Oncoclínicas operates 120 clinics across Brazil, serving over 1.5 million patients annually. The restructuring aims to improve governance and financial stability.
Mar 2026valorinternationalNews article
Fleury acquires Femme, a women’s health diagnostic lab, expanding its presence in specialized healthcare services. The deal values Femme at R$207 million, reflecting growing investment in women’s health diagnostics. Fleury integrates Femme’s expertise to strengthen its portfolio of medical testing solutions.
Nov 2025valorinternationalNews article
